80 related articles for article (PubMed ID: 16885561)
21. Mobilization, collection, and characterization of peripheral blood hemopoietic progenitors after chemotherapy with epirubicin, paclitaxel, and granulocyte-colony stimulating factor administered to patients with metastatic breast carcinoma.
Pedrazzoli P; Ponchio L; Zibera C; Da Prada GA; della Cuna GR
Cancer; 1999 May; 85(10):2295-6. PubMed ID: 10326711
[No Abstract] [Full Text] [Related]
22. Quality of life in women with breast cancer during the first year after random assignment to adjuvant treatment with marrow-supported high-dose chemotherapy with cyclophosphamide, thiotepa, and carboplatin or tailored therapy with Fluorouracil, epirubicin, and cyclophosphamide: Scandinavian Breast Group Study 9401.
Brandberg Y; Michelson H; Nilsson B; Bolund C; Erikstein B; Hietanen P; Kaasa S; Nilsson J; Wiklund T; Wilking N; Bergh J;
J Clin Oncol; 2003 Oct; 21(19):3659-64. PubMed ID: 14512398
[TBL] [Abstract][Full Text] [Related]
23. Acute non-lymphocytic leukaemia complicating gastric cancer treated with epipodophyllotoxin containing chemotherapy and G-CSF.
Stathopoulos GP; Moschopoulos N; Apostolopoulou E; Papakostas P; Samelis GF
Acta Oncol; 1994; 33(6):713-4. PubMed ID: 7524575
[No Abstract] [Full Text] [Related]
24. Leukaemia cutis in a patient treated for breast cancer.
Weinel S; Malone J; Jain D; Callen JP
Australas J Dermatol; 2009 Feb; 50(1):52-5. PubMed ID: 19178494
[TBL] [Abstract][Full Text] [Related]
25. High-dose sequential epirubicin and cyclophosphamide with peripheral blood stem cell support for advanced breast cancer: results of a phase II study.
Cottu PH; Extra JM; Espie M; Marolleau JP; de Roquancourt A; Makke J; Miclea JM; Laurence V; Mayeur D; Lerebours F; Cuvier C; Marty M
Br J Cancer; 2001 Nov; 85(9):1240-6. PubMed ID: 11720455
[TBL] [Abstract][Full Text] [Related]
26. Intensive cyclic chemotherapy and transplantation of autologous peripheral blood progenitor cells (PBPC) or whole blood in high-risk breast cancer - follow up at 10 years.
Cinek P; Filip S; Vanasek J; Mericka P; Blaha M; Zouhar M
Exp Oncol; 2007 Jun; 29(2):144-51. PubMed ID: 17704748
[TBL] [Abstract][Full Text] [Related]
27. Addition of either lonidamine or granulocyte colony-stimulating factor does not improve survival in early breast cancer patients treated with high-dose epirubicin and cyclophosphamide.
Papaldo P; Lopez M; Cortesi E; Cammilluzzi E; Antimi M; Terzoli E; Lepidini G; Vici P; Barone C; Ferretti G; Di Cosimo S; Nistico C; Carlini P; Conti F; Di Lauro L; Botti C; Vitucci C; Fabi A; Giannarelli D; Marolla P
J Clin Oncol; 2003 Sep; 21(18):3462-8. PubMed ID: 12972521
[TBL] [Abstract][Full Text] [Related]
28. [Feasibility of a cyclophosphamide methotrexate and 5-fluorouracil regime intravenously administered with and without granulocyte-colony stimulating factor in surgically treated breast carcinoma].
Garrone O; Del Mastro L; Mariani GL; Ardizzoni A; Venturini M; Rosso R
Minerva Med; 1993 Sep; 84(9):467-72. PubMed ID: 7504219
[TBL] [Abstract][Full Text] [Related]
29. Primary chemotherapy with epirubicin and vinorelbine in women with locally advanced breast cancer.
Nisticò C; De Matteis A; Rossi E; Carnino F; Valenza R; Agostara B; Bria E; Farris A; Cremonesi M; D'Ottavio AM; Vaccaro A; Garufi C; Giunta S; Botti C; Perrone F; Terzoli E
Anticancer Res; 2005; 25(2B):1343-8. PubMed ID: 15865089
[TBL] [Abstract][Full Text] [Related]
30. Phase I/II clinical trial of epirubicin and paclitaxel followed by granulocyte colony-stimulating factor in a 2-week schedule in patients with advanced or metastatic breast cancer.
Ries F; Duhem C; Kleiber K; Dicato M
Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-48-S17-51. PubMed ID: 9374093
[TBL] [Abstract][Full Text] [Related]
31. Can the addition of prophylactic filgrastim be considered cost effective in early breast cancer patients treated with epirubicin and cyclophosphamide?
Ferretti G; Papaldo P
J Clin Oncol; 2006 Dec; 24(35):5615-6; author reply 5616. PubMed ID: 17158552
[No Abstract] [Full Text] [Related]
32. Intensive cyclic chemotherapy with unprocessed whole blood support in advanced breast cancer.
Vanásek J; Filip S; Medková V; Bláha M; Maricka P; Stránský P; Vavrová J
Neoplasma; 2001; 48(1):34-8. PubMed ID: 11327535
[TBL] [Abstract][Full Text] [Related]
33. Phase I/II study of dose-intense doxorubicin/paclitaxel/cyclophosphamide with peripheral blood progenitor cells and cytokine support in patients with metastatic breast cancer.
Rahman Z; Champlin R; Rondon G; Frye D; Valero V; Mehra R; Hortobagyi G
Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-77-S17-80. PubMed ID: 9374100
[TBL] [Abstract][Full Text] [Related]
34. Risk of acute leukemia following epirubicin-based adjuvant chemotherapy: a report from the National Cancer Institute of Canada Clinical Trials Group.
Crump M; Tu D; Shepherd L; Levine M; Bramwell V; Pritchard K
J Clin Oncol; 2003 Aug; 21(16):3066-71. PubMed ID: 12915595
[TBL] [Abstract][Full Text] [Related]
35. Adjuvant high-dose chemotherapy with epirubicin and ifosfamide in nodal positive breast cancer.
Lüftner D; Wagner K; Dingeldein G; Haas A; Sezer O; Mergenthaler HG; Wernecke KD; Possinger K
Anticancer Res; 1999; 19(4C):3583-90. PubMed ID: 10629656
[TBL] [Abstract][Full Text] [Related]
36. Granulocyte colony-stimulating factor: key (f)actor or innocent bystander in the development of secondary myeloid malignancy?
Touw IP; Bontenbal M
J Natl Cancer Inst; 2007 Feb; 99(3):183-6. PubMed ID: 17284707
[No Abstract] [Full Text] [Related]
37. High-dose chemotherapy and autologous stem cell support followed by posttransplantation doxorubicin as initial therapy for metastatic breast cancer.
deMagalhaes-Silverman M; Bloom E; Lembersky B; Lister J; Pincus S; Rybka W; Voloshin M; Wilson J; Ball E
Clin Cancer Res; 1997 Feb; 3(2):193-7. PubMed ID: 9815672
[TBL] [Abstract][Full Text] [Related]
38. High-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy: analysis by age.
Antman K; Ayash L; Elias A; Wheeler C; Schwartz G; Mazanet R; Tepler I; Schnipper LE; Frei E
J Natl Cancer Inst Monogr; 1994; (16):91-4. PubMed ID: 7528031
[TBL] [Abstract][Full Text] [Related]
39. Mobilization, collection, and characterization of peripheral blood hemopoietic progenitors after chemotherapy with epirubicin, paclitaxel, and granulocyte-colony stimulating factor administered to patients with metastatic breast carcinoma.
Bengala C; Pazzagli I; Tibaldi C; Favre C; Vanacore R; Greco F; Mazzoni A; Menconi MC; Macchia P; Conte PF
Cancer; 1998 Mar; 82(5):867-73. PubMed ID: 9486575
[TBL] [Abstract][Full Text] [Related]
40. Granulocyte colony-stimulating factor and severe aplastic anemia.
Alter BP; Rosenberg PS
Blood; 2007 May; 109(10):4589; author reply 4589-90. PubMed ID: 17483301
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
